Fidelity Advisor Small Cap Growth A (FCAGX)

Fund Assets	8.80B
Expense Ratio	1.147%
Min. Investment	$0.00
Turnover	97.00%
Dividend (ttm)	n/a
Dividend Yield	n/a
Dividend Growth	n/a
Payout Frequency	Semi-Annual
Ex-Dividend Date	Sep 11, 2026

Previous Close	30.10
YTD Return	13.96%
1-Year Return	13.66%
5-Year Return	24.84%
52-Week Low	28.75
52-Week High	41.46
Beta (5Y)	1.16
Holdings	359
Inception Date	Nov 4, 2004

About FCAGX

The investment seeks capital appreciation. The fund invests primarily in common stocks. It invests at least 80% of its assets in securities of companies with small market capitalizations. The fund invests in companies that Fidelity Management & Research Company (FMR) believes have above-average growth potential (stocks of these companies are often called "growth" stocks). It invests in domestic and foreign issuers. The fund uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments.

• Fund Family: Fidelity
• Category: Small Growth
• Performance Rating: High
• Risk Rating: Average
• Stock Exchange: Nasdaq
• Ticker Symbol: FCAGX
• Share Class: Class A
• Index: Russell 2000 Growth TR

Performance

FCAGX had a total return of 13.66% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.99%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
FIDGX	Fidelity Advisor Small Cap Growth Fund: Class Z	0.79%
FCIGX	Fidelity Advisor Small Cap Growth Fund: Class I	0.90%
FCTGX	Fidelity Advisor Small Cap Growth Fund: Class M	1.40%
FCCGX	Fidelity Advisor Small Cap Growth Fund: Class C	1.90%

Top 10 Holdings

10.88% of assets

Name	Symbol	Weight
Fidelity Cash Central Fund	n/a	1.70%
BrightSpring Health Services, Inc.	BTSG	1.36%
Enova International, Inc.	ENVA	1.15%
Cogent Biosciences, Inc.	COGT	1.11%
InterDigital, Inc.	IDCC	1.03%
Intapp, Inc.	INTA	1.01%
Enliven Therapeutics, Inc.	ELVN	0.95%
Rush Street Interactive, Inc.	RSI	0.87%
Spyre Therapeutics, Inc.	SYRE	0.87%
Xometry, Inc.	XMTR	0.84%

Dividend History

Ex-Dividend	Amount	Pay Date
Sep 11, 2026	$7.090	Sep 14, 2026
Dec 12, 2025	$0.771	Dec 15, 2025
Sep 12, 2025	$1.461	Sep 15, 2025
Dec 13, 2024	$0.009	Dec 16, 2024
Sep 13, 2024	$0.363	Sep 16, 2024
Dec 17, 2021	$1.050	Dec 20, 2021

Data Sources: Tiingo, Financial Modeling Prep, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Financial Modeling Prep. Several fund data points are also provided by Finnhub.

Last checked:

Nov 3, 2026

Data Sources Report a data error